Table 3 Plasma lipid profile (mg/dL) and atherogenic indices (TC/HDL-C and Non HDL-C) of the different sub-groups.

From: Management of metabolic syndrome by nutraceuticals prepared from chitosan and ferulic acid with or without beta-sitosterol and their nanoforms

Group

TC

HDL-C

TC/HDL-C

Non HDL-C

LDL-C

TG

NC

84.38a ± 1.74

46.75a ± 1.82

1.83a ± 0.1

37.63a ± 2.83

19.8 a ± 2.9

89.0a ± 2.10

MC

307.50b ± 11.40

39.40b ± 1.27

7.84b ± 0.3

268.1b ± 10.9

236.4 b ± 9.9

158.5b ± 6.50

A

197.80c ± 6.14

43.25a ± 1.31

4.58c ± 0.2

154.1c ± 5.7

131.9 c ± 5.8

110.7c ± 4.60

N1

259.80d ± 6.00

38.40b ± 1.29

6.84d ± 0.3

221.4d ± 6.6

197.4 d ± 5.8

120.1d ± 5.04

NN1

267.50d ± 6.53

40.50b ± 1.05

6.63d ± 0.2

227d ± 6.5

201.8 d ± 6.5

125.6d ± 2.50

N2

277.50e ± 5.05

40.40b ± 1.28

6.93d ± 0.3

237.1d ± 5.4

210.5 d ± 5.4

133.2df ± 1.98

NN2

275.30d ± 6.20

40.60b ± 0.5

6.8d ± 0.2

234.6d ± 6.4

207.1d ± 6.2

137.4f ± 2.00

AN1

122.00f ± 2.58

47.25a ± 1.63

2.61e ± 0.1

74.75e ± 2.99

53.9e ± 3.4

104.1ce ± 3.50

ANN1

123.60f ± 2.80

45.25a ± 0.77

2.7eg ± 0.1

78.38e ± 3.54

58.6 e ± 3.7

98.75ae ± 3.04

AN2

148.50g ± 3.60

46.75a ± 1.39

3.2fg ± 0.1

101.8f ± 3.4

80.3f ± 3.8

107.2ce ± 4.30

ANN2

155.60g ± 3.10

46.00a ± 1.16

3.4f ± 0.1

109.6f ± 3.6

87.7f ± 3.1

109.8ce ± 3.80

  1. Values are expressed as means ± SE (n = 8). Significance was considered at p < 0.05 within columns where different letters indicate statistical significance.
  2. .NC control normal, MC metabolic syndrome control, A rats given atorvastatin drug, N1 rats received nutraceutical 1, NN1 rats treated with nutraceutical 1nanostructure, N2 rats received nutraceutical 2, NN2 rats given nutraceutical 2 nanostructure, AN1 rats taken atorvastatin drug with nutraceutical 1, ANN1 rats given atorvastatin drug with nutraceutical 1 nanostructure, AN2 rats treated with atorvastatin drug with nutraceutical 2, ANN2 rats received atorvastatin drug with nutraceutical 2 nanostructure, TC total cholesterol, TG triglycerides, HDL-C high density lipoprotein-cholesterol, LDL-C low density lipoprotein-cholesterol.